| 亞洲大學 |
2019-12 |
Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk
|
MING-HSIEN, W;WU, MING-HSIEN;TZEN, HUEY-EN;TZENG, HUEY-EN;WU, CHENG-NAN;WU, CHENG-NAN;YUE, TE-CHENG;YUEH, TE-CHENG;PEN, YEN-CHUN;PENG, YEN-CHUN;TSA, CHUN-HAO;TSAI, CHUN-HAO;WANG, YUN-CHI;WANG, YUN-CHI;KE, TAO-WEI;KE, TAO-WEI;PE, JEN-SHENG;PEI, JEN-SHENG;CHA, WEN-SHIN;CHANG, WEN-SHIN;包大?;Bau, Da-Tian |
| 臺大學術典藏 |
2018-09-10T18:05:09Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang, S.-H.;Lee, J.-C.;Guo, J.-C.;Kuo, S.-H.;Tien, Y.-W.;Kuo, T.-C.;Cheng, A.-L.;Yeh, K.-H.; TING-CHUN KUO; YU-WEN TIEN; JEN-CHIEH LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2020-02-20T06:53:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; YU-WEN TIEN; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2017 |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; Kuo T.-C.; Tien Y.-W.; Kuo S.-H.; JEN-CHIEH LEE; Guo J.-C.; Yang S.-H.; Yang S.-H.;Jen-Chieh Lee;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-09-29T06:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yeh K.-H.; Cheng A.-L.; TING-CHUN KUO; Tien Y.-W.; Kuo S.-H.; Guo J.-C.; Lee J.-C.; Yang S.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:22Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.;Lee J.-C.;Guo J.-C.;Kuo S.-H.;Tien Y.-W.;Kuo T.-C.;Cheng A.-L.;Kun-Huei Yeh; Yang S.-H.; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-08-12T04:01:25Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
YANG SHIH-HUNG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-18T07:39:07Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
Yang S.-H.; Lee J.-C.; JHE-CYUAN GUO; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:04Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2021-08-10T03:53:03Z |
Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy
|
SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H. |
